{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:10:04Z","timestamp":1792894204406,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This longitudinal observational study aimed to evaluate whether cardiometabolic factors and dietary characteristics are determinants of metabolic dysfunction-associated steatotic liver disease (MASLD) in non-obese individuals (body mass index [BMI]\u2009&lt;\u200925\u00a0kg\/m\u00b2). The study was conducted at the Japanese Red Cross Society Kyoto Daiichi Hospital. Clinical data were longitudinally recorded at annual health checks. The diagnosis of MASLD was based on the results of abdominal ultrasonography and cardiometabolic criteria. Lifestyle behaviors and dietary characteristics were assessed using a self-administered questionnaire. A total of 4,100 non-obese middle-aged and older participants (1,636 men and 2,464 women) were followed up for an average of 6.44\u2009\u00b1\u20094.16 years. During the follow-up period, there were 410 new cases of MASLD in men (25.1%) and 484 in women (19.6%). The incidence rate was higher for men (39.7 per 1,000 person-years) than for women (30.1 per 1,000 person-years). Multivariable-adjusted logistic regression analyses using the rate of change per year with standardized values found that BMI gain was strongly associated with the onset of MASLD for both men (OR: 1.90, 95% CI: 1.64\u20132.19) and women (OR: 1.95, 95% CI: 1.72\u20132.21). Increased waist circumference and triglycerides were also associated with MASLD onset for both men and women. Lowering of high-density lipoprotein cholesterol was identified as a risk factor for MASLD in both men and women. Regarding dietary characteristics, the onset of MASLD was significantly and negatively associated with \u201coften eating vegetables\u201d for men (OR: 0.73, 95% CI: 0.57\u20130.93) and \u201coften eating soy products\u201d for women (OR: 0.71, 95% CI: 0.58\u20130.88), even after adjusting for BMI change and other covariates. These findings suggest that maintaining body weight and favorable dietary characteristics are key factors in the prevention of MASLD in non-obese individuals.<\/jats:p>","DOI":"10.1038\/s41598-025-86424-x","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:37:14Z","timestamp":1737437834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals"],"prefix":"10.1038","volume":"15","author":[{"given":"Hirokazu","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatomo","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"86424_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520 (2023).","journal-title":"Hepatology"},{"key":"86424_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003 (2023).","journal-title":"J. Hepatol."},{"key":"86424_CR3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"European Association for the Study of the, L., European Association for the Study of, D. & European Association for the Study of, O","year":"2016","unstructured":"European Association for the Study of the, L., European Association for the Study of, D. & European Association for the Study of, O.EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59, 1121\u20131140. https:\/\/doi.org\/10.1007\/s00125-016-3902-y (2016).","journal-title":"Diabetologia"},{"key":"86424_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree, A., Broderick, L., Canbay, A., Hoffman, H. M. & Feldstein, A. E. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 10, 627\u2013636. https:\/\/doi.org\/10.1038\/nrgastro.2013.149 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"86424_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/hep.32542","volume":"77","author":"PA Shah","year":"2023","unstructured":"Shah, P. A., Patil, R. & Harrison, S. A. NAFLD-related hepatocellular carcinoma: The growing challenge. Hepatology 77, 323\u2013338. https:\/\/doi.org\/10.1002\/hep.32542 (2023).","journal-title":"Hepatology"},{"key":"86424_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani, A. et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: An updated systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 6, 903\u2013913. https:\/\/doi.org\/10.1016\/S2468-1253(21)00308-3 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"86424_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384. https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology"},{"key":"86424_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","volume":"28","author":"J Quek","year":"2022","unstructured":"Quek, J. et al. Metabolic Associated fatty liver Disease increases the risk of systemic complications and mortality. A Meta-analysis and systematic review of 12 620 736 individuals. Endocr. Pract. 28, 667\u2013672. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.016 (2022).","journal-title":"Endocr. Pract."},{"key":"86424_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.014","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. et al. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.014 (2024).","journal-title":"J. Hepatol."},{"key":"86424_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.1840120505","volume":"12","author":"IR Wanless","year":"1990","unstructured":"Wanless, I. R. & Lentz, J. S. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 12, 1106\u20131110. https:\/\/doi.org\/10.1002\/hep.1840120505 (1990).","journal-title":"Hepatology"},{"key":"86424_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan, J. G., Kim, S. U. & Wong, V. W. New trends on obesity and NAFLD in Asia. J. Hepatol. 67, 862\u2013873. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.003 (2017).","journal-title":"J. Hepatol."},{"key":"86424_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14218\/JCTH.2016.00068","volume":"5","author":"R Kumar","year":"2017","unstructured":"Kumar, R. & Mohan, S. Non-alcoholic fatty liver disease in lean subjects: Characteristics and implications. J. Clin. Transl. Hepatol. 5, 216\u2013223. https:\/\/doi.org\/10.14218\/JCTH.2016.00068 (2017).","journal-title":"J. Clin. Transl Hepatol."},{"key":"86424_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752. https:\/\/doi.org\/10.1016\/S2468-1253(20)30077-7 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"86424_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","volume":"15","author":"T Ito","year":"2021","unstructured":"Ito, T. et al. The epidemiology of NAFLD and lean NAFLD in Japan: A meta-analysis with individual and forecasting analysis, 1995\u20132040. Hepatol. Int. 15, 366\u2013379. https:\/\/doi.org\/10.1007\/s12072-021-10143-4 (2021).","journal-title":"Hepatol. Int."},{"key":"86424_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","volume":"114","author":"Y Chang","year":"2019","unstructured":"Chang, Y. et al. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: A Cohort Study. Am. J. Gastroenterol. 114, 620\u2013629. https:\/\/doi.org\/10.14309\/ajg.0000000000000074 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"86424_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/joim.13069","volume":"288","author":"B Zou","year":"2020","unstructured":"Zou, B. et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016. J. Intern. Med. 288, 139\u2013151. https:\/\/doi.org\/10.1111\/joim.13069 (2020).","journal-title":"J. Intern. Med."},{"key":"86424_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/gut.2008.161885","volume":"58","author":"Y Chang","year":"2009","unstructured":"Chang, Y. et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 58, 1419\u20131425. https:\/\/doi.org\/10.1136\/gut.2008.161885 (2009).","journal-title":"Gut"},{"key":"86424_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jgh.12861","volume":"30","author":"T Kimura","year":"2015","unstructured":"Kimura, T. et al. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals. J. Gastroenterol. Hepatol. 30, 909\u2013917. https:\/\/doi.org\/10.1111\/jgh.12861 (2015).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"86424_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.14309\/ajg.0000000000001030","volume":"116","author":"G Yamada","year":"2021","unstructured":"Yamada, G. et al. Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese Japanese individuals. Am. J. Gastroenterol. 116, 733\u2013740. https:\/\/doi.org\/10.14309\/ajg.0000000000001030 (2021).","journal-title":"Am. J. Gastroenterol."},{"key":"86424_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","volume":"38","author":"M Plauth","year":"2019","unstructured":"Plauth, M. et al. ESPEN guideline on clinical nutrition in liver disease. Clin. Nutr. 38, 485\u2013521. https:\/\/doi.org\/10.1016\/j.clnu.2018.12.022 (2019).","journal-title":"Clin. Nutr."},{"key":"86424_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige, K. et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J. Gastroenterol. 56, 951\u2013963. https:\/\/doi.org\/10.1007\/s00535-021-01796-x (2021).","journal-title":"J. Gastroenterol."},{"key":"86424_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/hepr.13688","volume":"51","author":"K Tokushige","year":"2021","unstructured":"Tokushige, K. et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. Hepatol. Res. 51, 1013\u20131025. https:\/\/doi.org\/10.1111\/hepr.13688 (2021).","journal-title":"Hepatol. Res."},{"key":"86424_CR23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323 (2023).","journal-title":"Hepatology"},{"key":"86424_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00394-015-0851-z","volume":"55","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults. Eur. J. Nutr. 55, 327\u2013333. https:\/\/doi.org\/10.1007\/s00394-015-0851-z (2016).","journal-title":"Eur. J. Nutr."},{"key":"86424_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13889","author":"A Kado","year":"2023","unstructured":"Kado, A. et al. Triglyceride level and soft drink consumption predict nonalcoholic fatty liver disease in nonobese male adolescents. Hepatol. Res. https:\/\/doi.org\/10.1111\/hepr.13889 (2023).","journal-title":"Hepatol. Res."},{"key":"86424_CR26","doi-asserted-by":"publisher","first-page":"e13082","DOI":"10.1002\/jgh3.13082","volume":"8","author":"H Taniguchi","year":"2024","unstructured":"Taniguchi, H., Ueda, M., Sano, F., Kobayashi, Y. & Shima, T. Dietary characteristics associated with the risk of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease in non-obese Japanese participants: A cross-sectional study. JGH Open. 8, e13082. https:\/\/doi.org\/10.1002\/jgh3.13082 (2024).","journal-title":"JGH Open."},{"key":"86424_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1079\/phn2003585","volume":"7","author":"BA Swinburn","year":"2004","unstructured":"Swinburn, B. A., Caterson, I., Seidell, J. C. & James, W. P. Diet, nutrition and the prevention of excess weight gain and obesity. Public. Health Nutr. 7, 123\u2013146. https:\/\/doi.org\/10.1079\/phn2003585 (2004).","journal-title":"Public. Health Nutr."},{"key":"86424_CR28","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1056\/NEJMoa1014296","volume":"364","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C. & Hu, F. B. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl. J. Med. 364, 2392\u20132404. https:\/\/doi.org\/10.1056\/NEJMoa1014296 (2011).","journal-title":"N Engl. J. Med."},{"key":"86424_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.35772\/ghm.2021.01109","volume":"4","author":"J Lu","year":"2022","unstructured":"Lu, J., Ningen & Dock Japan\u2019s unique comprehensive health checkup system for early detection of disease. Glob Health Med. 4, 9\u201313. https:\/\/doi.org\/10.35772\/ghm.2021.01109 (2022).","journal-title":"Glob Health Med."},{"key":"86424_CR30","doi-asserted-by":"publisher","unstructured":"Kudo, M. et al. JSUM ultrasound elastography practice guidelines: Liver. J. Med. Ultrason. (2001) 40, 325\u2013357. https:\/\/doi.org\/10.1007\/s10396-013-0460-5 (2013).","DOI":"10.1007\/s10396-013-0460-5"},{"key":"86424_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0009-9260(05)80350-2","volume":"43","author":"AE Joseph","year":"1991","unstructured":"Joseph, A. E., Saverymuttu, S. H., al-Sam, S., Cook, M. G. & Maxwell, J. D. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin. Radiol. 43, 26\u201331. https:\/\/doi.org\/10.1016\/s0009-9260(05)80350-2 (1991).","journal-title":"Clin. Radiol."},{"key":"86424_CR32","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/hep.23135","volume":"50","author":"R Haring","year":"2009","unstructured":"Haring, R. et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 50, 1403\u20131411. https:\/\/doi.org\/10.1002\/hep.23135 (2009).","journal-title":"Hepatology"},{"key":"86424_CR33","unstructured":"A Standard Health Checkup and Health Guidance Program (10 English Version). In Health Department of the Ministry of Health LaW (2007)."},{"key":"86424_CR34","first-page":"633","volume":"56","author":"F Hayashi","year":"2009","unstructured":"Hayashi, F., Yokoyama, T. & Yoshiike, N. Dietary intake and health behavior in relation to total and disease-specific mortality in Japan: An ecological analysis. Nihon Koshu Eisei Zasshi 56, 633\u2013644 (2009). (in Japanese).","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"86424_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","volume":"50","author":"K Nishioji","year":"2015","unstructured":"Nishioji, K. et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011\u20132012. J. Gastroenterol. 50, 95\u2013108. https:\/\/doi.org\/10.1007\/s00535-014-0948-9 (2015).","journal-title":"J. Gastroenterol."},{"key":"86424_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114520000914","volume":"124","author":"K He","year":"2020","unstructured":"He, K., Li, Y., Guo, X., Zhong, L. & Tang, S. Food groups and the likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Br. J. Nutr. 124, 1\u201313. https:\/\/doi.org\/10.1017\/S0007114520000914 (2020).","journal-title":"Br. J. Nutr."},{"key":"86424_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3177\/jnsv.69.251","volume":"69","author":"H Taniguchi","year":"2023","unstructured":"Taniguchi, H., Kobayashi, Y., Shima, T., Ueda, M. & Wada, S. Favorable dietary patterns associated with lower incidence of metabolic syndrome in middle-aged Japanese men: A prospective cohort study. J. Nutr. Sci. Vitaminol (Tokyo). 69, 251\u2013258. https:\/\/doi.org\/10.3177\/jnsv.69.251 (2023).","journal-title":"J. Nutr. Sci. Vitaminol (Tokyo)"},{"key":"86424_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12876-020-01369-x","volume":"20","author":"H Fujii","year":"2020","unstructured":"Fujii, H. et al. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: A retrospective cohort study. BMC Gastroenterol. 20, 217. https:\/\/doi.org\/10.1186\/s12876-020-01369-x (2020).","journal-title":"BMC Gastroenterol."},{"key":"86424_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.2040-1124.2012.00207.x","volume":"3","author":"A Kashiwagi","year":"2012","unstructured":"Kashiwagi, A. et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan diabetes society to national glycohemoglobin standardization program values. J. Diabetes Investig. 3, 39\u201340. https:\/\/doi.org\/10.1111\/j.2040-1124.2012.00207.x (2012).","journal-title":"J. Diabetes Investig"},{"key":"86424_CR40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"86424_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12944-021-01457-1","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou, Y. et al. LDL\/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: A 5-year longitudinal cohort study. Lipids Health Dis. 20, 28. https:\/\/doi.org\/10.1186\/s12944-021-01457-1 (2021).","journal-title":"Lipids Health Dis."},{"key":"86424_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1210\/jc.2015-3308","volume":"101","author":"H Taniguchi","year":"2016","unstructured":"Taniguchi, H., Tanisawa, K., Sun, X., Kubo, T. & Higuchi, M. Endurance exercise reduces hepatic fat content and serum fibroblast growth factor 21 levels in elderly men. J. Clin. Endocrinol. Metab. 101, 191\u2013198. https:\/\/doi.org\/10.1210\/jc.2015-3308 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"86424_CR43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archinte.167.10.999","volume":"167","author":"S Kodama","year":"2007","unstructured":"Kodama, S. et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: A meta-analysis. Arch. Intern. Med. 167, 999\u20131008. https:\/\/doi.org\/10.1001\/archinte.167.10.999 (2007).","journal-title":"Arch. Intern. Med."},{"key":"86424_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1440-1746.2007.05212.x","volume":"23","author":"BJ Park","year":"2008","unstructured":"Park, B. J. et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J. Gastroenterol. Hepatol. 23, 900\u2013907. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05212.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"86424_CR45","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","volume":"22","author":"N Motamed","year":"2016","unstructured":"Motamed, N. et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J. Gastroenterol. 22, 3023\u20133030. https:\/\/doi.org\/10.3748\/wjg.v22.i10.3023 (2016).","journal-title":"World J. Gastroenterol."},{"key":"86424_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170012","volume":"8","author":"M Alves-Bezerra","year":"2017","unstructured":"Alves-Bezerra, M. & Cohen, D. E. Triglyceride metabolism in the liver. Compr. Physiol. 8, 1\u20138. https:\/\/doi.org\/10.1002\/cphy.c170012 (2017).","journal-title":"Compr. Physiol."},{"key":"86424_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/DMSO.S396011","volume":"16","author":"D Yang","year":"2023","unstructured":"Yang, D., Lan, J., Cen, J., Han, Y. & Hu, H. Association between hypertension and new-onset non-alcoholic fatty liver disease in Chinese non-obese people: A longitudinal cohort study. Diabetes Metab. Syndr. Obes. 16, 345\u2013363. https:\/\/doi.org\/10.2147\/DMSO.S396011 (2023).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"86424_CR48","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.numecd.2019.01.016","volume":"29","author":"KC Sung","year":"2019","unstructured":"Sung, K. C. et al. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. Nutr. Metab. Cardiovasc. Dis. 29, 489\u2013495. https:\/\/doi.org\/10.1016\/j.numecd.2019.01.016 (2019).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"86424_CR49","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/jech-2020-214568","volume":"74","author":"SA Kim","year":"2020","unstructured":"Kim, S. A. & Shin, S. Fruit and vegetable consumption and non-alcoholic fatty liver disease among Korean adults: A prospective cohort study. J. Epidemiol. Community Health. 74, 1035\u20131042. https:\/\/doi.org\/10.1136\/jech-2020-214568 (2020).","journal-title":"J. Epidemiol. Community Health"},{"key":"86424_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1753-4887.2009.00189.x","volume":"67","author":"JW Anderson","year":"2009","unstructured":"Anderson, J. W. et al. Health benefits of dietary fiber. Nutr. Rev. 67, 188\u2013205. https:\/\/doi.org\/10.1111\/j.1753-4887.2009.00189.x (2009).","journal-title":"Nutr. Rev."},{"key":"86424_CR51","doi-asserted-by":"publisher","first-page":"593735","DOI":"10.3389\/fnut.2020.593735","volume":"7","author":"H Zhao","year":"2020","unstructured":"Zhao, H. et al. Association between dietary fiber intake and non-alcoholic fatty liver disease in adults. Front. Nutr. 7, 593735. https:\/\/doi.org\/10.3389\/fnut.2020.593735 (2020).","journal-title":"Front. Nutr."},{"key":"86424_CR52","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1017\/S0007114515002603","volume":"114","author":"OA Tokede","year":"2015","unstructured":"Tokede, O. A., Onabanjo, T. A., Yansane, A., Gaziano, J. M. & Djousse, L. Soya products and serum lipids: A meta-analysis of randomised controlled trials. Br. J. Nutr. 114, 831\u2013843. https:\/\/doi.org\/10.1017\/S0007114515002603 (2015).","journal-title":"Br. J. Nutr."},{"key":"86424_CR53","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1080\/10408398.2019.1689097","volume":"60","author":"M Moradi","year":"2020","unstructured":"Moradi, M., Daneshzad, E. & Azadbakht, L. The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: A systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 60, 3414\u20133428. https:\/\/doi.org\/10.1080\/10408398.2019.1689097 (2020).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"86424_CR54","doi-asserted-by":"publisher","first-page":"102692","DOI":"10.1016\/j.ctim.2021.102692","volume":"59","author":"Z Mosallanezhad","year":"2021","unstructured":"Mosallanezhad, Z. et al. Soy intake is associated with lowering blood pressure in adults: A systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Complement. Ther. Med. 59, 102692. https:\/\/doi.org\/10.1016\/j.ctim.2021.102692 (2021).","journal-title":"Complement. Ther. Med."},{"key":"86424_CR55","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3945\/ajcn.110.007187","volume":"93","author":"ZM Liu","year":"2011","unstructured":"Liu, Z. M., Chen, Y. M. & Ho, S. C. Effects of soy intake on glycemic control: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 93, 1092\u20131101. https:\/\/doi.org\/10.3945\/ajcn.110.007187 (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"86424_CR56","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/ajcn\/nqz338","volume":"111","author":"J Tang","year":"2020","unstructured":"Tang, J. et al. Legume and soy intake and risk of type 2 diabetes: A systematic review and meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 111, 677\u2013688. https:\/\/doi.org\/10.1093\/ajcn\/nqz338 (2020).","journal-title":"Am. J. Clin. Nutr."},{"key":"86424_CR57","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10654-020-00655-y","volume":"35","author":"P Qin","year":"2020","unstructured":"Qin, P. et al. Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: A dose-response meta-analysis of prospective cohort studies. Eur. J. Epidemiol. 35, 655\u2013671. https:\/\/doi.org\/10.1007\/s10654-020-00655-y (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"86424_CR58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1210\/jc.2010-2061","volume":"96","author":"X Wang","year":"2011","unstructured":"Wang, X., Magkos, F. & Mittendorfer, B. Sex differences in lipid and lipoprotein metabolism: It\u2019s not just about sex hormones. J. Clin. Endocrinol. Metab. 96, 885\u2013893. https:\/\/doi.org\/10.1210\/jc.2010-2061 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"86424_CR59","doi-asserted-by":"publisher","first-page":"04060","DOI":"10.7189\/jogh.14.04060","volume":"14","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. Association between processed and unprocessed red meat consumption and risk of nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis. J. Glob Health. 14, 04060. https:\/\/doi.org\/10.7189\/jogh.14.04060 (2024).","journal-title":"J. Glob Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86424-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:37:18Z","timestamp":1737437838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86424-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86424"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86424-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2606"}}